Twin Tree Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,400
Closed -$1.22M 1484
2025
Q3
$1.22M Buy
+6,400
New +$1.14M 0.01% 1150
2021
Q4
Sell
-5,000
Closed -$727K 1628
2021
Q3
$727K Buy
+5,000
New +$732K ﹤0.01% 1239
2017
Q1
Sell
-13,400
Closed -$1.23M 1061
2016
Q4
$1.23M Buy
+13,400
New +$1.15M 0.01% 736
2016
Q3
Sell
-7,100
Closed -$578K 1178
2016
Q2
$578K Buy
+7,100
New +$541K 0.01% 800
2015
Q4
Sell
-9,000
Closed -$553K 1420
2015
Q3
$553K Buy
9,000
+6,400
+246% +$447K 0.01% 743
2015
Q2
$189K Buy
+2,600
New +$192K ﹤0.01% 1077

Other funds holding DGX

Twin Tree Management's DGX Position: Q2 2026 in Review

Twin Tree Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 2,097 shares worth $444K. The stake represents 0.01% of the portfolio and ranks #1050 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in DGX as recently as Q3 2025.

Twin Tree Management first reported a position in DGX in Q1 2015 and has held it in 22 quarters since. The position peaked at $29.4M in Q4 2021. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Twin Tree Management held 2,097 shares of Quest Diagnostics worth $444K as of Q2 2026.
  • Quest Diagnostics was a new Twin Tree Management position in Q2 2026.
  • Quest Diagnostics made up 0.01% of Twin Tree Management's portfolio in Q2 2026, its #1050 holding.
  • Twin Tree Management first reported a position in Quest Diagnostics in Q1 2015 and has held it in 22 quarters since.
  • Twin Tree Management's Quest Diagnostics position peaked at $29.4M in Q4 2021.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Twin Tree Management's 13F filing for Q2 2026, filed 12 Aug 2026.